Canada markets closed

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.11000.0000 (0.00%)
At close: 01:55PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 6.52M
Enterprise Value 6.47M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.50
Price/Book (mrq)N/A
Enterprise Value/Revenue 18.28
Enterprise Value/EBITDA -1.69

Trading Information

Stock Price History

Beta (5Y Monthly) 0.97
52-Week Change 3-56.00%
S&P500 52-Week Change 3-9.85%
52 Week High 30.2500
52 Week Low 30.0700
50-Day Moving Average 30.0998
200-Day Moving Average 30.1091

Share Statistics

Avg Vol (3 month) 38.41k
Avg Vol (10 day) 39.46k
Shares Outstanding 554.36M
Implied Shares Outstanding 6N/A
Float 816.15M
% Held by Insiders 185.66%
% Held by Institutions 10.00%
Shares Short (Jan 12, 2023) 424.57k
Short Ratio (Jan 12, 2023) 42.35
Short % of Float (Jan 12, 2023) 40.07%
Short % of Shares Outstanding (Jan 12, 2023) 40.05%
Shares Short (prior month Dec 14, 2022) 45.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 09, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Aug 09, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-418.95%

Management Effectiveness

Return on Assets (ttm)-165.10%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)353.74k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)353.74k
EBITDA -1.48M
Net Income Avi to Common (ttm)-3.85M
Diluted EPS (ttm)-0.1160
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)95.31k
Total Cash Per Share (mrq)0
Total Debt (mrq)731.68k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.15
Book Value Per Share (mrq)-0.22

Cash Flow Statement

Operating Cash Flow (ttm)-1.69M
Levered Free Cash Flow (ttm)-968.03k